Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$1.43B |
| 2 |
Boeing
BA
|
+$1.39B |
| 3 |
Perrigo
PRGO
|
+$1.11B |
| 4 |
McKesson
MCK
|
+$960M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.56B |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$2.21B |
| 3 |
Gilead Sciences
GILD
|
+$1.99B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.79B |
| 5 |
Norfolk Southern
NSC
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.47% |
| 2 | Technology | 12.22% |
| 3 | Communication Services | 12.18% |
| 4 | Industrials | 10.66% |
| 5 | Consumer Staples | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Herbalife
HLF
$1.23B
| $311M | 0.11% |
10,098,746
-10,968,200
| -52% | -$283M |
|
177
Wells Fargo
WFC
$269B
| $310M | 0.11% |
6,412,300
-11,081,000
| -63% | -$543M |
|
178
Ultragenyx Pharmaceutical
RARE
$2.65B
| $302M | 0.1% |
4,766,473
+10,000
| +0.2% | +$654K |
|
179
C.H. Robinson
CHRW
$17.1B
| $300M | 0.1% |
+4,047,794
| New | +$278M |
|
180
Southern Company
SO
$106B
| $285M | 0.1% |
5,500,000
| – | – |
|
|
WFM
181
DELISTED
Whole Foods Market Inc
WFM
| $284M | 0.1% |
9,115,700
-6,013,000
| -40% | -$188M |
|
182
East-West Bancorp
EWBC
$18.5B
| $282M | 0.1% |
8,680,000
| – | – |
|
183
AutoNation
AN
$6.9B
| $280M | 0.1% |
6,000,000
| – | – |
|
184
AptarGroup
ATR
$8.47B
| $280M | 0.1% |
3,570,000
| – | – |
|
|
DNY
185
DELISTED
DONNELLEY R R & SONS CO
DNY
| $279M | 0.1% |
17,011,043
-152,315
| -0.9% | -$2.5M |
|
186
Williams-Sonoma
WSM
$28.9B
| $275M | 0.09% |
10,052,000
| – | – |
|
187
Pfizer
PFE
$150B
| $275M | 0.09% |
9,775,850
| – | – |
|
|
KITE
188
DELISTED
Kite Pharma, Inc.
KITE
| $275M | 0.09% |
5,982,753
+43,200
| +0.7% | +$2.09M |
|
189
Analog Devices
ADI
$187B
| $275M | 0.09% |
4,639,826
| – | – |
|
|
SYNT
190
DELISTED
Syntel Inc
SYNT
| $273M | 0.09% |
5,458,043
+770,000
| +16% | +$35.3M |
|
191
NextEra Energy
NEE
$179B
| $268M | 0.09% |
9,072,000
| – | – |
|
192
Autodesk
ADSK
$52.7B
| $264M | 0.09% |
4,530,000
| – | – |
|
|
YHOO
193
DELISTED
Yahoo Inc
YHOO
| $263M | 0.09% |
7,133,198
+1,589,500
| +29% | +$49.8M |
|
194
CME Group
CME
$94.3B
| $262M | 0.09% |
2,727,000
-1,663,000
| -38% | -$151M |
|
195
Alexandria Real Estate Equities
ARE
$8.27B
| $260M | 0.09% |
2,855,904
+400,000
| +16% | +$32.6M |
|
|
AVP
196
DELISTED
Avon Products, Inc.
AVP
| $256M | 0.09% |
53,255,341
+1,400,000
| +3% | +$5M |
|
197
Truist Financial
TFC
$64.3B
| $255M | 0.09% |
7,661,000
-2,629,000
| -26% | -$87.3M |
|
198
Oshkosh
OSK
$9.61B
| $255M | 0.09% |
6,235,600
| – | – |
|
199
Principal Financial Group
PFG
$24.4B
| $247M | 0.09% |
6,271,000
-2,729,600
| -30% | -$105M |
|
|
CBPO
200
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $244M | 0.08% |
2,127,277
+1,802,277
| +555% | +$211M |
|
Similar funds
Capital Research Global Investors's Q1 2016 Portfolio in Review
As of Q1 2016, Capital Research Global Investors held 454 positions worth $290B, down 0.74% from $292B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Capital Research Global Investors's Q1 2016 filing shows 18 new, 121 increased, 127 reduced and 24 closed positions. Its largest new stake was Perrigo: 8,089,200 shares worth $1.03B. The largest sale was Alphabet (Google) Class C, an estimated $2.56B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2016 buy was Perrigo: 8,089,200 shares worth $1.03B.
- Capital Research Global Investors added most to Netflix in Q1 2016, an estimated $1.43B increase.
- Capital Research Global Investors's biggest Q1 2016 reduction was Alphabet (Google) Class C, cutting an estimated $2.56B.
- Capital Research Global Investors fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $2.21B.
- Capital Research Global Investors's ten largest holdings make up 24% of its $290B portfolio in Q1 2016.
- Capital Research Global Investors opened 18 new positions and closed 24 in Q1 2016.
- Capital Research Global Investors's portfolio value fell 0.74% quarter-over-quarter to $290B.
Based on Capital Research Global Investors's 13F filing for Q1 2016, filed 16 May 2016.